Exploration of the Italian response to COVID-19 pandemic

ISRCTN ISRCTN26200758
DOI https://doi.org/10.1186/ISRCTN26200758
ClinicalTrials.gov number Nil Known
Submission date
01/04/2021
Registration date
11/05/2021
Last edited
14/06/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
The COVID-19 pandemic outbreak is placing an overwhelming burden on health systems and authorities to respond with effective and appropriate interventions, policies and messages. The pandemic and its restrictions may have affected mental and physical well-being, social cohesion, economic stability as well as individual and community resilience and trust.
In this complex context, understanding how, why and the context in which humans and communities respond allows to 1) anticipate unwanted scenarios and initiate mitigating measures; and 2) implement pandemic response measures that are better informed, situated, accepted and thus more effective.
This study is part of the large project promoted by the World Health Organization (WHO) called “Monitoring knowledge, risk perceptions, preventive behaviours and trust to inform pandemic outbreak response” and conducted in over 30 countries of the WHO European Region.
This is an observational study with voluntary participation in the general population, with expected low risk for participants. In Italy, the survey is conducting administering a questionnaire online developed ad hoc by the WHO in four waves (from January to May 2021) to a national representative sample of aged 18-70, stratified for different dimensions.

Who can participate?
General population 18-70 years old

What does the study involve?
Participants complete an online questionnaire.

What are the possible benefits and risks of participating?
Potential risks identified include only the inconvenience of the time taken to respond to the survey, and given the current restrictions people face, many individuals currently have more available time. Benefits include the sense of contributing and being able to participate in shaping the country’s pandemic response.

Where is the study run from?
IRCCS Istituto Centro San Giovanni di Dio, Fatebenefratelli (Italy)

When is the study starting and how long is it expected to run for?
October 2020 to September 2021

Who is funding the study?
The italian project has been funded by Fondazione Cariplo and IRCCS Istituto Centro San Giovanni di Dio, Fatebenefratelli (Italy)

Who is the main contact?
Giovanni de Girolamo, M.D., gdegirolamo@fatebenefratelli.eu

Study website

Contact information

Dr Giovanni de Girolamo
Scientific

U.O. Psychiatric Epidemiology and Evaluation
IRCCS Istituto Centro San Giovanni di Dio, Fatebenefratelli
Via Pilastroni 4
Brescia
25125
Italy

ORCiD logoORCID ID 0000-0002-1611-8324
Phone +39 (0)303501590
Email gdegirolamo@fatebenefratelli.eu
Dr Valentina Candini
Scientific

St John of God Clinical Research Centre
v. Pilastroni 4
Brescia
25121
Italy

ORCiD logoORCID ID 0000-0003-4062-7847
Phone +39 030 3501 333
Email vcandini@fatebenefratelli.eu
Dr Cristina Zarbo
Scientific

St John of God Clinical Research Centre
v. Pilastroni 4
Brescia
25121
Italy

ORCiD logoORCID ID 0000-0002-6613-4445
Phone +39 030 3501 329
Email czarbo@fatebenefratelli.eu
Dr Chiara Buizza
Scientific

St John of God Clinical Research Centre
v. Pilastroni 4
Brescia
25121
Italy

ORCiD logoORCID ID 0000-0002-3339-3539
Phone +39 030 3501 333
Email chiara.buizza@unibs.it

Study information

Study designObservational cross sectional study
Primary study designObservational
Secondary study designCross sectional study
Study setting(s)Internet/virtual
Study typeOther
Participant information sheet https://www.euro.who.int/__data/assets/pdf_file/0007/436705/COVID-19-survey-tool-and-guidance.pdf
Scientific titleMonitoring knowledge, risk perceptions, preventive behaviours and trust to inform pandemic outbreak response - Italian study
Study acronymCOVID-WHO-ITALY
Study objectivesThe study aims to gain insights into risk perception, knowledge, trusted sources of information, attitudes toward pandemic response initiatives and other variables to inform COVID-19 outbreak response measures, including policies, interventions and communications.
The primary objectives are to:
- Monitor variables that are critical for population behaviour to control transmission of the novel coronavirus, including risk perceptions, knowledge, self-efficacy, confidence in institutions, behaviours, rumours, affect, worry, resilience, trust in/use of information sources and more
- Document changes over time in these factors to understand the effect of the pandemic process, new developments, events or measures taken
- Monitor possible issues, e.g. related to misinformation or distrust, as they emerge, to allow early response
- Identify relationships between variables to identify levers for effective and appropriate responses
- Explore the relationship of psychological variables (e.g. worry, resilience, trust, affect) with the epidemiological situation and the events and measures taken
- Identify gaps between perceived and actual knowledge
- Evaluate the effectiveness of pandemic response measures, and the acceptance and effectiveness of policies and restrictions implemented, including the easing of such restrictions
Ethics approval(s)Approved 03/12/2020, Ethical Committee of IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (25125 BRESCIA – Via Pilastroni, 4, Italy; +39 303501586; ceioc@fatebenefratelli.it), ref: 286/2020
Health condition(s) or problem(s) studiedExploration of the Italian response to COVID-19 pandemic
InterventionThis study is part of a large project promoted by the World Health Organization (WHO) called “Monitoring knowledge, risk perceptions, preventive behaviours and trust to inform pandemic outbreak response” and conducted in over 30 countries of the WHO European Region.

In Italy, the survey is conducted through a questionnaire online developed ad hoc by WHO; the questionnaire is being administered in four waves (January-May 2021) to a national representative sample of people aged 18-70. A detailed sampling plan was adopted to obtain a representative sample of the Italian adult population.

The following variables were taken into account for the stratification of the participants: gender by age (4 age groups: 18-34 years, 35-44 years, 45-54 years, 55-70 years), geographical area (4 areas: North West, North East, Centre, South and Islands), size of living centers (2 classes: above and below 100,000 inhabitants), level of education (up to lower middle school, beyond lower middle school), and employment situation (employed, not employed). At the end of each survey’s wave, a weighting procedure is applied to accurately restore the proportionality of the total sample examined with the reference population, according to the most recent data of the Italian Statistics Institute (ISTAT). In particular, data are weighted for the main socio-demographic and geographic variables (e.g., sex, age, occupation, educational qualification, region and demographic size of the centers).
Intervention typeOther
Primary outcome measureAll measures have been collected in just one session (questionnaire administration), by means of a structured questionnaire developed ad hoc by WHO. Variables are measured using validated questions or adapted validated questions. The WHO questionnaire includes 21 different thematic areas noteworthy for the investigation of COVID-19 experience. The questionnaire was translated into Italian language, following the WHO’s guidelines for translations of tools into other languages.
1. Socio-demography. Items developed ad hoc including age, gender, education, medical background, chronic illness, rural/urban, district, household, financial situation (risk group identified as: 70+ years and/or chronic illness)
2. COVID-19 personal experience. Items developed ad hoc including COVID-19 infection (own, someone close)
3. Health literacy. Items adapted from: Sørensen K, Van den Broucke S, Pelikan JM, et al. (2013) and Griebler, Robert; Nitsche, Michael (2020)
4. COVID-19 risk perception: Probability and Severity. Validated items adapted from Brewer, N. T., Chapman, G. B., Gibbons, F. X., Gerrard, M., McCaul, K. D., & Weinstein, N. D. (2007)
5. Preparedness and Perceived self-efficacy. Psychological construct: preparedness -validated items adapted from: Bandura, A. (2006). Psychological construct: perceived self-efficacy - validated items adapted from: Renner, B., & Schwarzer, R. (2005)
6. Prevention – own behaviours. Items adapted from: Steel Fisher GK et al (2012)
7. Affect related to COVID-19. Validated items adapted from: Bradley, M. M., & Lang, P. J. (1994)
8. Trust in sources of information: Schweitzer, M. E., Hershey, J. C., & Bradlow, E. T. (2006) and Pearson, S. D., & Raeke, L. H. (2000)
9. Use of sources of information. Items developed ad hoc including use of information sources (television, newspapers, health workers, social media, radio, Ministry of Health, Institute of Public Health, hotlines, official website, celebrities)
10. Frequency of Information. Items developed ad hoc including frequency in information for different sources (television, newspapers, health workers, social media, radio, Ministry of Health, Institute of Public Health, hotlines, official website, celebrities)
11. Trust in institutions (perceptions): Schweitzer, M. E., Hershey, J. C., & Bradlow, E. T. (2006) and Pearson, S. D., & Raeke, L. H. (2000)
12. Policies, interventions (perceptions). Items developed ad hoc including Perceptions related to possible/real government policies (COVID-19 vaccine, discrimination behaviours, testing, exaggeration in restrictions, quarantine)
13. Conspiracies (perceptions). Validated items taken from: Bruder M, Haffke P, Neave N, Nouripanah N, Imhoff R. (2013)
14. Resilience (perceptions). Validated items taken from: Smith, B. W., Dalen, J., Wiggins, K., Tooley, E., Christopher, P., & Bernard, J. (2008)
15. Testing and tracing. Items grounded in theory: Michie et al (2014)
16. Fairness (perceptions). Validated items taken from: Gamliel, E., & Peer, E. (2010)
17. Lifting restrictions (pandemic transition phase). Items developed ad hoc including perceptions related to lifting restrictions (adapted to country decisions made/considered
18. Unwanted behaviour. Items developed ad hoc including reported own behaviour (discrimination, physical exercise, alcohol, diet, smoking, vaccination postponed, drugs against COVID-19, postponed doctor visit)
19. Well-being. Validated items from: WHO 5-item well-being scale (WHO-5)
20. COVID-19 vaccine. Items grounded in theory: Michie et al (2014)
Secondary outcome measuresThere are no secondary outcome measures
Overall study start date01/10/2020
Completion date21/05/2021

Eligibility

Participant type(s)Population
Age groupAdult
Lower age limit18 Years
Upper age limit70 Years
SexBoth
Target number of participants10,000
Total final enrolment10013
Key inclusion criteriaGeneral population 18-70 years old
Key exclusion criteriaCurrent isolation due to COVID-19 infection
Date of first enrolment03/01/2021
Date of final enrolment21/05/2021

Locations

Countries of recruitment

  • Italy

Study participating centres

IRCCS Istituto Centro San Giovanni di Dio, Fatebenefratelli
Via Pilastroni, 4
Brescia
25125
Italy
AUSL Modena - Dipartimento Salute Mentale e Dipendenze Patologiche
Viale Ludovico Antonio Muratori,201
Modena
41124
Italy
Istituto Superiore di Sanità - Centro di Riferimento per le Scienze comportamentali e la Salute mentale
Viale Regina Elena 299
Roma
00161
Italy

Sponsor information

Centro San Giovanni di Dio Fatebenefratelli
Research organisation

IRCCS
Via Pilastroni 4
Brescia
25125
Italy

Phone +39 (0)3035011
Email centro.sangiovanni.di.dio@fatebenefratelli.eu
Website https://www.fatebenefratelli.it/strutture/irccs-brescia
ROR logo "ROR" https://ror.org/02davtb12
Azienda Unita' Sanitaria Locale Di Modena
Hospital/treatment centre

Dept of Mental Health
Via S Giovanni del Cantone 23
Modena
41121
Italy

Phone +39 (0)59435111
Email f.starace@ausl.mo.it
Website http://www.ausl.mo.it/home
ROR logo "ROR" https://ror.org/0018xw886
Istituto Superiore di Sanità
Government

Viale Regina Elena 299
Rome
00161
Italy

Phone +39 0649901
Email gemma.calamandrei@iss.it
Website http://www.iss.it
ROR logo "ROR" https://ror.org/02hssy432

Funders

Funder type

Charity

Fondazione Cariplo
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
Cariplo Foundation
Location
Italy
IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli

No information available

Results and Publications

Intention to publish date01/10/2021
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryStored in publicly available repository
Publication and dissemination planPlanned publication in high-impact peer-reviewed journal.
IPD sharing planThe datasets generated during and/or analysed during the current study will be stored in a publically available repository. (Zenodo, https://zenodo.org/); there will be a 2-year embargo, although it will always be possible to write to the coordinators to propose scientific collaborations based on this dataset. After the embargo, to obtain the dataset it will be necessary to write to the study coordinators. Raw data will be shared: all data are fully anonymised and it was obtained written permission from all study participants for the sharing of completely anonymised data for scientific purposed. This is also stated in the permission obtained from the Ethical Committee.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 26/10/2022 14/06/2023 Yes No
Results article 17/11/2022 14/06/2023 Yes No

Editorial Notes

14/06/2023: Publication references added.
04/06/2021: The following changes were made to the trial record:
1. The overall end date was changed from 30/09/2021 to 21/05/2021.
2. The total final enrolment was added.
02/06/2021: The following changes were made to the trial record:
1. The recruitment end date was changed from 30/06/2021 to 21/05/2021.
2. Three scientific contacts were added.
06/04/2021: Trial's existence confirmed by Ethical Committee of IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli.